Business NewsPR NewsWire • ScinoPharm to Engage in Strategic Collaboration with Raffles

ScinoPharm to Engage in Strategic Collaboration with Raffles

ScinoPharm to Engage in Strategic Collaboration with Raffles

CHANGSHU, China, June 22, 2015 /PRNewswire/ -- ScinoPharm Taiwan, Ltd. (TWSE: 1789) and Raffles PharmaTech announced today the collaboration to manufacture "Celecoxib," a non-steroidal and anti-inflammatory analgesic active pharmaceutical ingredient (API). By combining the R&D...

View More : http://www.prnewswire.com/news-releases/scinopharm-to-engage-in-strategic-collaboration-with-raffles-300101974.html
Releted News by prnewswire
Ellomay Capital Reports Results for the First Quarter of 2015
NuCana Appoints Martin J Birkhofer, M.D. as Chief Medical Officer
ScinoPharm to Engage in Strategic Collaboration with Raffles
La platforme de luxe en ligne Luxify.com et Landscope Christie's instaurent un partenariat pour répondre à l'intérêt croissant de la chine pour les investissements dans des exploitations viticoles
Infortrend #1 in SPC-1 IOPS per Dollar